Introduction
The manifestations of kidney disease are protean and include acute kidney injury (AKI) due to ischaemiareperfusion or direct tubular cytotoxicity; autoimmune glomerulonephritis; and rejection of kidney transplants through mechanisms that affect the glomerular, interstitial and vascular compartments. Increasing molecular evidence now demonstrates the pivotal role of nonparenchymal cells in determining both renal tissue injury and subsequent reparative responses following diverse insults. In particular, advances in technology and the understanding of innate and adaptive immunopathological cellular responses have facilitated identification of dendritic cells (DCs) and macrophages, as well as assessment of their function, in nonlymphoid solid organs such as the kidney. Both of these cell types reside within the renal interstitium, and possess the capacity to activate and regulate both protective and deleterious renal pathology. DCs have long been established as indispensable antigen-presenting cells (APCs), which act as systemic sentinels capable of responding to endogenous and exo genous 'danger' signals to initiate and propagate immune responses to inciting antigens or induce immune tolerance. [1] [2] [3] Macrophages have been defined as a distinct, but related population of APCs (albeit less potent than DCs), whose primary functions are maintenance of tissue homeostasis and phagocytic clearance of various native and foreign bodies.
In this Review, we examine the archetypal components of the nonparenchymal compartment in the kidney. We consider the advances that have been made in understanding the discrete but overlapping roles of both DCs and macrophages-a difficult task owing to the substantial functional and phenotypic similarity between these mononuclear phagocyte populations ( Figure 1 ). We also discuss how innovations, such as the identification and assessment of distinct lineage markers and gene expression profiles, transgenic mouse models and cell ablation techniques, have facilitated the discrimination of DC and macrophage subsets that function in tissue homeo stasis and immune tolerance, acute and chronic inflammation and allo immunity. We note, however, that considerable limitations remain for many of these approaches, particularly related to the ability to accurately target DCs and/ or macro phages to modulate disease outcome, in addition to questions regarding their relevance to human kidney disease.
Defining DCs and macrophages
Considerable flexibility, heterogeneity and complexity is recognized within the myeloid-monocyte developmental lineage. 4 For example, both DCs and macrophages originate from common progenitor cells in the bone marrow under the influence of key growth factors ( Figure 2 ): colonystimulatin g factor 1 (CSF-1; also known as macro phage c olony-stimulatin g factor [M-CSF]), fms-like related tyrosine kinase 3 ligand (FLT3LG), and granulocyte-macrophage an important area of contention, and this issue remains controversial (Box 1). [10] [11] [12] [13] Currently, no definitive cellular demarcation has been established, and studies have tended to investigate either DCs or macro phages, with segregation based on traditional interpretations of identification. Specifically, such research efforts-predominantly in mouse models-have relied on the supposition that macro phages or DCs can be accurately identified according to expression levels of the 'macrophage' markers F4/80 (also known as EGF-like module-containing mucin-like hormone receptor-like 1 [EMR1]) and CD11b (integrin α M ) or the 'DC marker' CD11c (integrin α x ). How ever, these markers are not exclusive to their respective cell types ( Figure 1) ; bone-marrow-derived macrophages can express CD11c in vitro, whereas DCs can express F4/80 and CD11b, suggesting that these markers do not identify unique cell populations. 14, 15 The incomplete restriction of such cell-surface markers to specific cell types complicates the interpretation of experimental data based on this method of cell identification. In addition, this limitation Figure 1 | The heterogeneous but overlapping phenotype and functions of renal DCs and macrophages. DCs are traditionally described as mediators of immune surveillance and antigen presentation, and as the primary determinants of responses to antigens-through initiation of either immune effector-cell functions or the development of tolerance. Macrophages also function as innate immune cells, predominantly through phagocytosis and production of toxic metabolites. However, the classical paradigm of DC versus macrophage phenotypes and functions is increasingly indistinct within the kidney, as these cells exhibit overlapping surface markers, functional capabilities, and ontogenic pathways. This molecular and phenotypic overlap between cell types and subsets complicates their identification and evaluation. *Marker described only in humans. Abbreviations: B-ATF-3, basic leucine zipper transcription factor ATF-like 3; BDCA-1, blood dendritic cell antigen 1; CCR, CC chemokine receptor; CSF-1R, colony-stimulating factor 1 receptor; CX3CR1, CX3C chemokine receptor 1; DC, dendritic cell; DC-SIGN, dendritic-cell-specific ICAM-3-grabbing non-integrin; ECM, extracellular matrix; EMR1, EGF-like module-containing mucin-like hormone receptor-like 1; FcγR(II/III), low affinity IgG Fc region receptor (II/III); FLT3, fms-like tyrosine kinase 3; Gr-1, granulocyte-differentiation antigen-1; ICAM-1, intercellular adhesion molecule 1; ID-2, inhibitor of DNA binding 2; IL-4R, IL-4 receptor; IL-10R, IL-10 receptor; IRF, interferon regulatory factor; Ly6(C/G), lymphocyte antigen 6(C/G); SIRPα, signal-regulatory protein α (also known as tyrosine-protein phosphatase nonreceptor type substrate 1); STAT3, signal transducer and activator of transcription 3; ZBTB46, zinc finger and BTB domain containing protein 46. should be considered when interpreting studies involving conditional cell ablation techniques that are dependent on transgene expression under the control of the CD11b 16 or the CD11c 17 promoter, as both DCs and macrophages, as well as other cell types might be affected. Hence, determining both the pattern and level of expression of multiple cell-surface markers-F4/80, CD11b, CD11c, integrin α E [CD103], and major histocompatibility complex (MHC) class II (MHC II), for example-might be informative and, if possible, is desirable. Analysis of transcription factors typically expressed by DCs or macrophages has also been used to characterize these cell types. 15 These caveats in defining macrophages and DCs are important to acknowledge, as they are suggestive of functional overlap between these cell types, depending on the biological context. Although DCs and macrophages do, indeed, seem to have overlapping functions, such as antigen uptake and presentation, several core activities of these cell types can be considered separately.
The basic DC and macrophage paradigm 
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Figure 2 | The ontogeny of kidney-resident DCs and macrophages. Bone-marrow-resident MDPs differentiate into monocytes that are released to the peripheral circulation under homeostatic and inflammatory conditions. MDPs also develop into CDPs, which subsequently differentiate to pre-DCs that can migrate from bone marrow to the renal interstitial compartment via the blood, with regular turnover. Under the influence of different chemokines and growth factors, the pre-DCs differentiate to form distinct, tissuebased DC subsets (broadly characterized as CX3CR1 + DCs or CD103 + DCs) that are capable of exodus to the draining lymph nodes where they can present antigens to B cells and T cells. Monocytes can also localize to the kidney under the influence of chemokines such as CCR2, and subsequently differentiate into DCs. Pre-DCs also give rise to pDC, although the presence of pDCs in kidneys of mice is disputed (dashed arrow). Abbreviations: B-ATF-3, basic leucine zipper transcription factor ATF-like 3; BDCA-(1/2), blood dendritic cell antigen (1/2); CCL(19/21), CC chemokine ligand (19/21); CCR(2/7), CC chemokine receptor (2/7); CDP, common dendritic cell precursor; CLEC4K, C-type lectin domain family 4 member K; CLEC9A, C-type lectin domain family 9 member A; CSF-1, colony-stimulating factor 1; CSF-1R, CSF-1 receptor; CX3CR1, CX3C chemokine receptor 1; DC, dendritic cell; DC-SIGN, dendritic-cell-specific ICAM-3-grabbing non-integrin; FLT3, fms-like tyrosine kinase 3; FLT3LG, FLT3 ligand; GM-CSF, granulocyte-macrophage colony-stimulating factor; Ly6(C/G), lymphocyte antigen 6(C/G); M-CSF, macrophage colony-stimulating factor; MDP, monocyte-DC precursor; pDC, plasmacytoid DC.
instigation of immunity or tolerance. 1, 18 As mentioned, DCs originate from myeloid haematopoietic progenitor cells in the bone marrow, via developmental pathways that exhibit considerable plasticity; 19 however, DC ontogenesis is governed predominantly by the haematopoietic growth factor FLT3LG (Figure 2) . [20] [21] [22] They are rare cells that are present in the peripheral circulation (<0.1% of total circulating leucocytes), but also reside in virtually all tissues (especially near portals of entry), and display broad maturational and functional diversity. 1, 18 In keeping with their role as potent APCs, DCs are highly proficient at both internalizing and processing antigens; 23 through a highly-orchestrated molecular process, the cells sub sequently present peptide fragments of processed foreign or self-antigen in the context of MHC class I or class II molecules to T cells that express complementary T-cell receptors (TCRs). 18 Once activated in the periphery, DCs exhibit enhanced migratory capacity and emigrate to secondary lymphoid organs to convey the processed antigens for T-cell stimulation, which requires both MHC-TCR inter actions and reinforcing signals induced by co-stimulatory molecules provided by the DC. 24 DC activation, maturation and migration are triggered by a wide array of cellsurface receptors for Toll-like receptor (TLR) ligands, C-type lectins, cytokines and chemokines involved in inflammatory responses (extensively reviewed elsewhere 3, 20, 25 ). Through these mechanisms, DCs control the initiation of naive and memory T-cell responses, 26 and mediate a critical link between the innate and a daptive immunological systems. 1, 18 Macrophages Similarly to DCs, macrophages comprise a diverse group of innate immune cell subsets that are particularly rich in lysosomes, and are adept at phagocytosis of tissue debris and infectious material. In addition, macrophages can regulate other cell types by serving as APCs, and also play a part in wound healing via the production of an array of cytokines, chemokines and growth factors. 27 The lineage profile of macrophage precursor populations originating in the bone marrow is similar to that of DCs, although macrophage development, differentiation and proliferation are primarily governed by CSF-1. 7, 28 Interestingly, postnatal administration of CSF-1 to mice increased kidney weight and tissue macrophage number. 29 Macrophages arise at an early stage of organogenesis during fetal development; 30 in the kidney specifically, their presence precedes the appearance of nephrons, and macrophage cell types seem to have a predominantly trophic role at prenatal stages of kidney development. 30 Although the commonly accepted tenet is that macrophage renewal within the interstitial compartment of solid tissues is driven by differentiation of haematopoietic stem cells, emerging evidence suggests a contribution from embryonic progenitor cells, 31, 32 as well as in situ proliferation of tissue macrophages. 9, 33 The recognition that macrophages can adopt several phenotypes led to the 'M1' and 'M2' paradigm of macrophage development. According to this paradigm, M1 (also termed classically activated) macrophages are regarded as proinflammatory. 34 By contrast, M2 (alternatively activated) macrophages are considered to promote both wound healing and tissue fibrosis. 34 These phenotypes have been defined by in vitro experiments, and although undoubtedly simplistic, the M1-M2 macrophage concept emphasizes the fact that macrophages, similar to DCs, have inherent maturational and functional plasti city, suggesting that the phenotype of individual cells and cell populations can change and evolve over time in vivo. 35 ■ GM-CSF promotes DC development in vitro; GM-CSF produces alternative macrophages 198, 199 that are associated with a 'mature DC-type' cytokine profile
DCs/macrophages in homeostatic kidneys
Functional similarity ■ DCs and macrophages are both involved in tissue surveillance and are highly phagocytic ■ Many immunoregulatory factors, including cytokines and chemokines, can be produced by both cell types 15 ■ Although antigen-presenting capacity is typically attributed to DCs, macrophages can suppress T-cell activation in an antigen-specific manner 15, 200 Abbreviations: CSF-1, colony-stimulating factor 1 (also known as, macrophage colonystimulating factor); CSF-1R, CSF-1 receptor; DC, dendritic cell; EMR1; EGF-like modulecontaining mucin-like hormone receptor-like 1; FLT3LG, fms-like tyrosine kinase 3 ligand; GM-CSF, granulocyte-macrophage colony-stimulating factor.
virtually all lymphoid and nonlymphoid tissues, formal identification of renal DCs, particularly CD11c + DCs, had been disputed historically. The renal DC population was thought initi ally to be localized within the glomerular compartment and, therefore, to mediate the pathogenesis of glomerulonephritides. This assumption was supported by the isolation of rodent glomerular cells that were phenotypically distinct from mesangial cells, which expressed MHC II (I-A subclass) and exhibited T-cell allostimulatory capa city in primary mixed leucocyte cultures. [42] [43] [44] [45] Concurrent rodent and human studies confirmed the presence of cells positive for MHC II molecules within the cortical interstitium of the kidney. 46, 47 Furthermore, electron microscopic examination of rodent peritubular interstitium enabled differentiation of fibroblasts from immune cells with features suggestive of DCs (high expression of MHC II) or macrophages (abundant primary and secondary lysosomes). 48 Immunohistochemical identification of CD11c + DCs requires minimization of protein denaturation by avoiding high temperatures; 49 this technique has facilitated the detection and localization of these cells proximate to peritubular capillaries. 50 
Phenotypic characterization
In healthy mice, the renal CD11c + DC population is hetero geneous, expressing MHC II and low or intermediate levels of CD11b and F4/80. 50 Although these markers can also be expressed by macrophages, the renal DCs identified in mice more closely resembled splenic dendritic cells than peritoneal macrophages with regard to morpho logical, molecular (co-stimulatory molecule expression) and functional properties. 50 Furthermore, these cells exhibited allogeneic T-cell stimulatory capacity, although to a lesser degree than observed with splenic CD11c + DCs. 50 Extensive phenotypic characterization revealed that conventional CD11c + DCs (cDCs) had an immature phenotype (low CD80 and CD86, and negligible CD40 expression) and substantial phagocytic capacity-in addition to the absence of nonconventional plasmacytoid DC (pDC) markers (CD8α and B220). Figure 2) . 51 Both of these renal DC subsets appear to undergo cell division and, therefore, proliferation in homeostatic renal tissue. 51 CD103 + renal DCs arise primarily from bone-marrow-derived precursors, pre-cDC, and express higher levels of DNA-binding protein inhibitor ID-2 and interferon regulatory factor 8 (IRF8) than the CD11b + subset, as well as FLT3. 51 Indeed, both the FLT3 receptor and its ligand, FLT3LG, are an absolute requirement for the development of this DC subset. 51 
CD11b
+ DCs express CSF-1 receptor (CSF-1R; also known as CD115), in keeping with a developmental bias towards this growth factor, but are also dependent on FLT3LG for complete reconstitution. 51 Although improvements in renal DC characterization have been made, the absolute numbers of these cells that can be isolated from the kidney remain relatively low compared with secondary lymphoid organ DC populations; 50 however, systemic administration of FLT3LG in mice 52 and nonhuman primates 53 enables expansion of both renal cDC and pDC populations in vivo. Ex vivo, these mobilized DCs, when freshly isolated, retained an immature phenotype and promoted the development of IL-10-producing T REG cells in mixed leucocyte reactions. 52 Low CC chemokine receptor (CCR1, CCR2, CCR5, and CCR7) transcript levels in these DCs reflect a failure to migrate in vitro in response to chemokines (CC chemokine ligand 3 [CCL3], CCL5, and CCL20); 52, 54 however, their capacity to migrate to the lymphoid-tissue-homing chemokines CCL19 and CCL20 could be augmented ex vivo by exposure to ba cterial l ipopolysaccharide (LPS). 54 Although no candidate precursor has been formally identified, renal-resident DCs are thought to be derived from common DC precursors that arise from bone marrow progenitors and subsequent blood-borne pre-DC precursors ( Figure 2 ) 55 -as demonstrated for CD103 + DCs. 51 Nevertheless, lymphocyte antigen 6C (Ly6C) -'patrolling' circulating monocytes might also contribute to renal-resident DC populations; Ly6C + potential DC precursors infiltrate the kidney under inflammatory conditions, 7, 9 influenced by the CX3C chemo kine receptor 1 (CX3CR1; also known as fractalkine receptor) and CCR2. 56 Macrophages, conventionally defined as CD11b + , express greater levels of CSF-1R compared with the CD11c + DC subset. 57 The CSF-1R-enhanced green fluor escent protein (eGFP) transgenic-reporter mouse (the so-called 'MacGreen' mouse; Table 1 ) has been used to track postnatal macrophage development. In this model, cells with active gene expression driven by the CSF-1R promoter were demonstrated to be present before nephro genesis, in close apposition to developing renal tubules, and increased in number after administration of CSF-1. 30 In adult kidneys, resident macrophages are believed to originate from bone-marrow-resident monocyte precursors, 58 which are characterized as lineage negative (Lin − ) cells that express CX3CR1 and the mast/stem cell growth factor receptor Kit (also known as CD117); additional recruitment of Ly6C + cells can occur under the influence of CCR2 (Figure 2) . 58, 59 Tissue macrophages derived from infiltrating monocytes can undergo differentiation into the broad M1 and M2 cate gories depending on context. Classically activated M1 macrophages are typically induced through encounter with danger-associated molecular patterns (DAMPs) or proinflammatory cytokines, and produce IL-12 and IL-23 (as do DCs) to promote CD4 + T-helper (T H ) cell polarization. 60, 61 Alternatively activated M2 macrophages can arise through deactivation and differentiation of M1 macrophages, or de novo, directly from infiltrating monocytes; 60 this subset is immunoregulatory, and produces anti-inflammatory IL-10 as well as Wnt7B. 62 
Studies in CX3CR1
eGFP/+ transgenic-reporter mice (Table 1) , 63 as well as the MacGreen model, 64 have provided evidence of DC-macrophage network within the kidney. The CX3CR1 eGFP/+ mouse model enables mapping of DCs and/or macrophages derived from CX3CR1 + monocytes emigrated from the bone marrow. This study confirmed the homeostatic presence of renal DCs throughout the entire interstitial scaffold, encasing glomeruli, as well as low numbers of these cells within the mesangial matrix. 63 In the MacGreen mouse, 64 macrophages were visualized surrounding glomeruli and encasing renal tubules within the medulla. The complexity of this renal-resident DC-macrophage network has been elegantly reinforced in a study demonstrating multiple discrete cell subsets, distinguished by cell-surface markers, cytokine production, and transcription factor and chemokine receptor expression, in the kidney; 15 the cell populations were initially defined according to expression levels of CD11b and CD11c. 15 Two defined subsets were found to exhibit a DC phenotype, with the ability to robustly stimulate CD4 + T-cell proliferation, including the induction of forkhead box protein P3 (FOXP3) + T REG cells. 15 However, these cell types also phagocytosed latex beads, and expressed the macrophage marker CD68 in conjunction with developmental and reparative growth factors, such as insulin-like growth factor 1, platelet derived growth factor and Wnt7B. 15 By contrast, two other cell subsets displayed a macrophage phenotype, characterized by phagocytic capability but an absent or limited capacity to induce T-cell proliferation. 15 These macrophage cell types also expressed growth factors and produced IL-10 after LPS stimulation. 15 Thus, these findings reiterate the concept that overlapping DC and macrophage characteristics should be considered in experimental studies or transgenic mice that use a single cell marker such as CD11b, CD11c, CX3CR1 or CSF-1R, as these are also all variably expressed by DC and macrophages in the normal kidney. A further limitation of current studies examining DCs and macrophages is that characterization of populations of these cells is based predominantly on whole kidney, rather than compartmentalized tissue digests. Different renal microenvironments could potentially be associated with distinct DC and macrophage subtypes, leading to erroneous conclusions regarding cell localization when whole kidney samples are analysed; for example, glomerular macrophages do not express F4/80, but can be identified based on CD68 positivity.
65,66

Models of macrophage and DC ablation
Various methods have been used to conditionally ablate macrophages and/or DCs in vivo, with the aim of dissecting their function in disease ( Table 2) . In early studies, liposomal clodronate formed the basis for cell ablation; this agent is toxic to many phagocytic cell types, but particularly macrophages, and systemic administration profoundly ablated macrophage populations in the kidney, as well as liver and spleen, such that the effects of cell ablation might have been secondary to intrarenal or extrarenal effects. [67] [68] [69] [70] [71] Despite these caveats, this approach has been used to deplete DCs and macrophages in multiple mouse and rat models of renal disease.
Selective cell ablation has been attempted using transgenic mice that express the human diphtheria toxin receptor (DTR; also known as heparin-binding EGFlike growth factor [HB-EGF]) under the control of the CD11b 16 or CD11c 17 promoter, to deplete macrophages or DCs, respectively, following diphtheria toxin (DT) administration. Although overlapping expression of these markers in DC or macrophage subsets as well as other cell types suggests that multiple cell populations are inevitably depleted (Table 2) , CD11b-DTR and CD11c-DTR mice have, nonetheless, proved highly informative. Despite the apparent simplicity of such celldepletion studies, multiple caveats-in addition to the technical caveats discussed-limit their interpretation as many possible explanations are available for the observed results. For example, reduced tissue injury after depletion of CD11c + cells could potentially be manifest through a number of mechanisms: production of injurious factors by the resident or infiltrating renal CD11c + cells that were depleted; production of protective factors by the residual surviving renal CD11c + cells, other haemato poietic cells or parenchymal cells subsequent to interaction with the apoptotic corpses of ablated cells, for example; promotion of systemic protective effects of renal or extra-renal CD11c + cell depletion (that is, skewing of immune responses); a protective effect attributable to regeneration of cell populations following transient Abbreviations: CSF-1R, colony-stimulating factor-1 receptor; CX3CR1, CX3C chemokine receptor 1; DC, dendritic cell; eGFP, enhanced green fluorescent protein.
REVIEWS depletion of CD11c
+ cells; or any combination of these potential mechanisms.
Although investigators have typically used a single cell-ablation method, the concurrent use of multiple strat egies can also be informative. For example, administration of liposomal clodronate to CD11b-DTR mice (in the absence of DT) markedly protected against renal ischaemia-reperfusion injury (IRI), whereas administration of DT to CD11b-DTR mice had no effect on injury. 72, 73 Intriguingly, the combined administration of both liposomal clodronate and DT provided no protection, indicating that the addition of DT removes the protective effect of the liposomal clodronate. 73 These data suggest that the phenotype of the surviving residual cells in the kidneys of liposomal-clodronate-treated mice, predominantly identified as CD206 + macrophages and CD11c + cells, 73 might be key to the protective effect observed. These potential caveats and complexities should be borne in mind when cell-ablation models are used.
Renal DC and macrophage functions
Intrarenal activities
Cell recruitment
Renal DCs seem to mediate the recruitment of other cell types with various immunological functions. In a mouse model of pyelonephritis caused by Escherichia coli, CD11c + renal DCs are the predominant producers of CXC chemokine ligand 2 (CXCL2), which drives the recruitment of neutrophils to facilitate bacterial clearance ( Figure 3) ; 74 this effect was abrogated after conditional DC ablation in CD11c-DTR mice. 74 
Renal repair
The progression of disease in many experimental models of kidney injury, such as chronic allograft and diabetic nephropathy, can be limited through various interventions, but these do not typically lead to renal regeneration. Renal regeneration does occur, however, following moderate AKI induced by renal IRI, and this setting has been used to explore the role of macrophages in renal repair; in particular, depletion of macrophages using either liposomal clodronate 75 or DT treatment of CD11b-DTR mice 62 during the reparative phase of IRI-induced AKI markedly retarded restoration of tubular integrity and renal function. Macrophage-derived Wnt7B and IL-22 (induced via TLR4) have been implicated as key mediators of renal repair and tubular regeneration in this context. 62, 76 Fibrosis Fibrosis is associated with progression of kidney disease to chronic renal impairment. 61, 77 That macrophages can promote the production of extracellular matrix by myofibroblasts and, therefore, scar formation by adopting a 'wound healing' M2 phenotype during inflammation is well established (Figure 4) ; in the kidney, this pathway is likely to be detrimental and, in AKI, might occur in conjunction with other profibrotic processes, such as epithelial cell-cycle arrest. 78 Indeed, macrophages have been implicated in the development of renal fibrosis, as administration of liposomal clodronate was found to be protective in the rodent unilateral ureteral obstruction (UUO) model. 79, 80 Interestingly, reduced fibrosis was demonstrated in DT-treated CD11b-DTR mice with UUO. 9, 81 In contrast, ablation of CD11c + cells in CD11c-DTR mice with UUO did not reduce renal scarring, 82, 83 despite the fact that increases in the maturation, activation and antigen-presenting capacity of renal DCs were reported in this setting. 83 Studies involving the use of bone-marrow-chimeric CD11b-DTR mice, in which either resident renal DCs and macrophages or infiltrating bone-marrow-derived cells were depleted, demonstrated that resident renal non parenchymal cells proliferate in UUO, but do not actively contribute to fibrosis; 9 the cells with a profibrotic transcriptional profile expressed low levels of Ly6C and had matured from kidney-infiltrating 'Ly6C high ' monocytes. 9 In addition, persistent proinflammatory macrophage activation has been shown to promote tubular atrophy and fibrosis after AKI. 84 Collectively, these data suggest that macrophages, rather than DCs, drive renal scarring.
The precise mechanism by which macrophages promote fibrosis in the kidney remains unclear. Transforming growth factor β1 (TGF-β1) is implicated in this process, as a key profibrotic cytokine ( Figure 4) ; however, mice lacking expression of this cytokine specifically in macrophages exhibited comparable levels of fibrosis to wild-type mice with IRI-induced AKI or UUO, suggesting that macrophage-derived TGF-β1 is not critical to fibrosis in these disease models. 85 Macrophage-derived mediators, such as the lectin galectin 3, 81 might be important to renal fibrosis, but further work is needed to clarify their identity and role in this process.
Extrarenal DC function
Following activation, renal DCs are known to traffic to draining lymph nodes (Figure 3) , where they present antigens. Several studies have provided additional insights into the behaviour of these DCs when exposed to antigenic material. CD11c + renal DCs preferentially and rapidly endocytose small (<40 kDa) molecules, compared with splenic DCs that predominantly endocytose larger antigenic material (>500 kDa). 86 DCs in the kidney-draining lymph nodes also endocytose lowmolecular-weight antigens that are transported to them by cell-independent mechanisms. Renal lymph-n odebased DCs, which express CD8, chemokine XC receptor 1 (XCR1; also known as the lymphotactin receptor), and basic leucine zipper transcriptional factor ATF-like 3 (B-ATF-3), are capable of antigen cross-presentation to subsequently delete cytotoxic T cells in a programmed death ligand 1 (PD-L1)-dependent manner. 87 These findings imply a necessary tolerogenic function for renal DCs that are continually exposed to innocuous antigens, such as serum and food proteins. This hypothesis is further supported by the finding that proteasomal processing of albumin by rat bone-marrow-derived renal DCs in vitro enables these cells to prime and subsequently activate CD8 + T cells. 88 Similar observations have been made in rats subjected to five-sixths nephrectomy to induce focal segmental glomerulosclerosis, which resulted in interstitial inflammation, including infiltration of CD11c + CD103 + DCs. 88 The cell infiltrates in the kidney were reduced in animals treated with the proteasome inhibitor bortezomib. 88 In this study, DCs isolated from kidney-draining lymph nodes in five-sixths nephrectomized mice activated syngeneic CD8 + T cells in a manner that was time-dependent and reduced by bortezomib treatment.
Systemic administration of LPS in mice initiates DC efflux from the kidney to the draining lymph nodes over 24-72 h. 89, 90 Renal subcapsular placement of ovalbumin and subsequent LPS administration results in DO11.10 (ovalbumin-specific) CD4 + T-cell proliferation in the ipsilateral renal lymph node, with antigen presentation mediated by CD11c + renal DCs. 89, 90 A similar DC migratory response has been seen following IRI. 89, 90 These findings are relevant mechanistically to the ex vivo analysis of FLT3LG-mobilized renal DCs that upregulate CCR7 in response to LPS (Figure 1) , 54 a necessary requirement for DC migration to draining lymph nodes, which is m ediated by CCL19 and CCL21 (Figure 2 ).
DCs/macrophages-roles in renal disease
Multiple rodent models of diverse clinical renal diseases are available (Table 3) , and can provide mechanistic insights into glomerular and tubular pathophysiology (reviewed elsewhere 91 ). We discuss a number of standard immunological and cytotoxin-based models of renal disease in which the roles of DCs and/or macrophages have been investigated extensively. 
Glomerulonephritides
Nephrotoxic nephritis
Mice injected with antiserum produced in sheep, rabbits or goats after vaccination with mouse renal cortex develop rapid and progressive glomerular damage, termed nephrotoxic nephritis. This condition mimics the crescentic glomerulonephritis seen in human autoimmune disease. 92 The glomerular-based antigenantibody complexes that are generated in this model are captured by both DCs and macrophages, and are subsequently presented to T cells (Table 3 ). The relevant APCs within the kidney during the initial 'injury' phase of nephrotoxic nephritis are typically CD11c + CD11b + cells with a maturing phenotype. Of note, depletion of these cells in CD11c-DTR mice at this early stage (day 4) exacer bated disease, suggesting an anti-inflammatory role for renal DCs; 93 however, depletion of CD11c + cells at a later stage (day 7) reduced the numbers of effector DCs and T cells, and attenuated disease, 93 supporting a proinflammatory role of DCs as they mature and implying a biphasic role for DCs in this disease process. 93 Renal DCs isolated from these mice induced CD4 + T-cell proliferation ex vivo, and promoted concurrent secretion of interferon (IFN)-γ and IL-10 in co-culture experiments; IL-10 levels were elevated at day 4 and increased over time whereas proinflammatory cytokine expression only seemed to be increased at day 10, again supporting the proinflammatory and anti-inflammatory roles of DCs.
93 Ly6G -renal DCs, rather than cells derived from infiltrating Ly6G + monocytes, seem to produce most of the proinflammatory tumour necrosis factor (TNF) and IL12/23p40 in this model. 93 Tubulointerstitial DCs have also been shown to release the proinflammatory cytokine IL-1β, via NACHT, LRR and PYD domains-containing protein 3 (NLRP3)-inflammasome-caspase-1 pathway activation. 94 DC depletion using CD11c-DTR mice provided additional evidence supporting a protective role for renal DCs in nephrotoxic nephritis, by demonstrating that deletion of these cells at days 4 or 10 after induction of disease aggravates the extent of injury. 95 The mechanism of DC-mediated renal protection in nephrotoxic nephritis seems to centre on IL-10 production and regulation of type 1 T H (T H 1)-cell responses. 96, 97 Initial evidence suggested that this effect might be mediated via expression of inducible co-stimulatory molecule ICOS-L specifically on renal DCs, which could promote IL-10 secretion by T cells that express its co-receptor. 98 Interestingly, expression of this protein by renal DCs has been shown to decrease concomitant with increased production of proinflammatory cytokines. 93 Macrophage ablation in CD11b-DTR mice has been shown to attenuate glomerular disease and tubular injury, and decrease effector CD4 + T-cell populations in crescentic glomerulonephritis models. 99 Other methods of abrogating macrophage function through blockade of factors involved in either recruitment or activation of these cells, such as CCL2, are also protective in glomerulone phritis, suggesting a proinflammatory role for renal macrophages. 100, 101 Further evidence of a proinflammatory role for renal macrophages in glomerulonephritis comes from a rat mesangioproliferative glomerulone phritis model. In this model, injection of mouse monoclonal antibody targeting thymocyte antigen 1a (Thy1.1) results in mesangial-based macrophage infiltration. 102 Other models of glomerulonephritis induced by antibodies targeting the glomerular basement membrane antibody also demonstrate ingress (or localization of adoptively transferred cells) and proliferation of monocyte-derived macro phages within glomeruli, correlating with histopathological severity; 103, 104 these phenomena can be reversed by inhibiting CSF-1, 105 or treatment with an anti-CD80/CD86 monoclonal antibody. 106 
Podocyte immunopathology in NOH mice
In a mouse model of podocyte immunopathology, in which antigens are expressed in glomerular podocytes (so-called NOH mice; Figure 4 | Macrophages in renal disease. Tissue-resident macrophages or infiltrating proinflammatory monocytes can become classically activated by exposure to dangerassociated molecular patterns or proinflammatory cytokines to take on an M1 phenotype, associated with production of IL-12 and IL-23, engagement of T cells for antigen presentation, activation or exacerbation of profibrotic parenchymal changes, and direct and indirect tissue injury. M1 macrophages can be reprogrammed to become alternatively activated M2 macrophages by stimulation with antiinflammatory cytokines, such as IL-10 or CSF-1, or ingestion of apoptotic cells. M2 macrophages might facilitate and coordinate restoration of tubular cell and, therefore, kidney tubule integrity following injury. M2 macrophages can also express antiinflammatory mediators, such as HO-1 and IL-10, which act to limit tissue injury and promote resolution of inflammation, but might also drive pericyte and myofibroblast activation through production of TGF-β, galectin 3 and PDGF. Abbreviations: AKI, acute kidney injury; CSF-1, colony-stimulating factor 1; ECM, extracellular matrix; HO-1, haem oxygenase-1; ICAM-1, intercellular adhesion molecule 1; M-CSF, macrophage colony-stimulating factor; PDGF, platelet-derived growth factor; TGF-β, transforming growth factor β; Wnt7b, wingless-related MMTV integration site 7B.
CD11c
+ Ly6G + DCs or CD11c low Ly6G + macrophages in the kidney. In this model of chronic glomerulonephritis, DCs produced IL-12 and upregulated the co-stimulatory mol ecules CD86 and CD40, indicating activation of these cells. In addition, the DC component, and consequently the periglomerular infiltrates, rapidly resolved after administration of DT to remove CD11c + cells in the progeny of NOH mice crossed with CD11c-DTR mice. 107 Presentation of antigen by DCs to CD4 + T cells was shown to occur intrarenally only, and facilitated accumulation of CD8 + cytotoxic T lymphocytes ( Figure 3 ).
Lupus nephritis
Systemic lupus erythematosus (SLE) is a common autoimmune disease with a clinical predilection for catastrophic renal involvement. Most studies in animal models of SLE have focused on the role of systemic DCs in disease pathogenesis. However, the role of kidney-resident DCs and macrophages in the initiation and progression of SLE-like disease are increasingly described (Table 3) . NZB/W F1 mice develop lupus nephritis spontaneously, and this disease is characterized histologically by + macrophages has been shown to correlate with disease severity, 108 and intrarenal CD11b
+ CD11c + cDCs were demonstrated to express CXCL13 (also known as B lympho cyte chemoattractant; Table 3 ) and, therefore, had the ability to recruit autoantibody-producing B cells. 109 With ageing, MRL-Fas lpr/lpr mice also develop lupus nephritis; in these mice, lupus nephritis correlated with renal expression of C1q (a subcomponent of the classical complement activation pathway), which was shown to be generated locally by renal CD11c + DCs. 110 The proinflammatory cytokine IL-12, produced intrarenally by both DCs and macrophages, promoted the accumu lation of IFN-γ-secreting T cells (Figure 3) , which exacer bated nephritis in these mice. 111 Not surprisingly, therefore, MRL-Fas lpr/lpr mice lacking IL-12 demonstrated reduced renal damage and decreased mononuclear cell infiltration into the kidney compared with wild-type MRL-Fas lpr/lpr mice; 111 by contrast, overexpression of CCL2 promoted monocyte recruitment to the kidney, and this effect was mitigated by blockade of the chemokine or its receptor (CCR2). Abbreviations: CTL, cytotoxic T lymphocyte; DC, dendritic cell; CXCL13, CXC chemokine ligand 13 (also known as B lymphocyte chemoattractant); HEL, hen-egg lysozyme; Ly6G, lymphocyte antigen 6G (also known as granulocyte-differentiation antigen-1); NOH, nephrin-OVA-HEL; OVA, ovalbumin; T REG , T regulatory.
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B6.TC mice also develop spontaneous glomerulonephritis concomitant with the production of autoantibodies. Compared to DCs isolated from B6 control mice, DCs isolated from B6.TC mice have higher T-cell allostimulatory capacity and block the suppressive function of CD4 + CD25 + T REG cells via overproduction of IL-6, 114 in addition to facilitating B-cell proliferation and autoantibody production (Table 3) .
115 NZM2328 mice also demonstrate a proliferative, gender-biased (female predilection, as in SLE) glomerulonephritis. 116 In this model, renal histology is characterized by intraglomerular CD11c + DCs that co-localize with T cells, 117 whereas F4/80 + macrophages are confined to peri-glomerular regions, suggesting that intrarenal DCs might mediate the presentation of (auto)antigen, thereby promoting disease progression (Table 3) .
Evidence from preclinical therapeutic studies Administration of the immunosuppressant cyclophosphamide and/or blockade of co-stimulatory signalling (using CTLA4-Ig fusion proteins or anti-CD40-ligand monoclonal antibodies) in NZB/W F1 mice was associated with a decrease in the number of CD11c + renal DCs and remission of lupus. 118 Amelioration of disease in MRL-Fas lpr/lpr mice, which was associated with reduced macrophage and T-cell infiltration into the kidney, has been demonstrated using a p38 mitogen-activated protein kinase inhibitor; 119 p38-inhibitor treatment also decreased the abundance of renal CD11c + DCs, including those with a mature phenotype that expressed high-mobility group protein B1. 120 pDCs have also been implicated in lupus pathogenesis by amelioration of lupus pathology in NZB mice genetically engineered to lack pDCs through del etion of the gene encoding IRF8, and in mice carrying a mutation in the Slc15a4 gene, which retain pDCs incapable of producing type I IFN. 121 In perinuclear antineutrophil cytoplasmic antibody (ANCA)-positive SCG/Kj mice that develop rapidly progressive glomerulo nephritis, 122 a novel triazolopyrimidine derivative (NK026680) that inhibits DC function was demonstrated to suppress multiple disease manifestations and the development of autoantibodies, providing additional evidence of the role of DCs in glomerulonephritis. 123 Manipulation of the humoral immune response through DC-mediated induction of immune tolerance might also represent an approach to mitigating disease in glomerulonephritis. Ligation of Fc receptors (particularly low affinity IgG Fc region receptor IIb [FcγRIIb]) by immunoglobulins, including endogenous antibodies and immune complexes derived from lupus-prone mice, have been shown to provide an inhibitory signal that prevents TLR-mediated DC maturation and enhances the tolerogenicity of this cell type. 124 Furthermore, adoptive transfer of immature DCs overexpressing FcγRIIb before or after the onset of clinical lupus attenuated lupus nephritis in MRL-Fas lpr/lpr mice. 124 Conversely, MRL-Fas lpr/lpr mice lacking FcγRIIb displayed greater B-cell activity and higher levels of DC-derived IL-12. 125 The finding that administration of C-reactive protein reverses renal manifestations of nephrotoxic nephritis in a macrophage-dependent manner suggests that this cell type might also be a valid target in glomerulonephritis. 126 Interestingly, immune complexes have also been shown to suppress macrophage inflammatory responses via FcγRIIb, 127 and this effect was protective in a cryoglobulin-associated membranoproliferative glomerulonephritis mouse model. 128 However, binding of tissue-bound antibody or immune complexes might also activate macrophages to produce proinflammatory mediators via activation of various signal transduction pathways, including spleen tyrosine kinase (SYK). In keeping with this possibility, the SYK inhibitor fostamatinib markedly ameliorated nephrotoxic nephritis in rats and limited macrophage activation following treatment with aggregated IgG. 129 
Acute kidney injury
IRI and cisplatin-induced kidney injury
Both IRI and administration of cisplatin can induce tubular epithelial cell coagulative necrosis, and both approaches have been used to study the role of renal DCs and macrophages in AKI. CD11b low F4/80 high DC and CD11b high F4/80 low macrophages (both differentiated from Ly6C high infiltrating cells) could be identified early (3 h) following IRI, with the numbers of these cells peaking at 24 h after IRI, and developing a predominantly macrophage phenotype. 56 Although ablation of DCs exacerbates cisplatin-induced AKI, 130 a similar DC-mediated protective effect has been disputed in models of IRI (Table 4) . 72, 131 On the other hand, macrophage ablation provided protection from renal injury in an IRI model, [132] [133] [134] and this protective effect was reversed by adoptive transfer of the mouse macrophage cell line, RAW 264.7. 75, 133 However, macrophages also seem to have distinct phenotypes depending on time post-injury in an IRI model: M1 characteristics predominated initially (1-3 days following reperfusion); whereas M2 skewing was observed during the proliferative repair phase (dependent on Wnt7b 62 and CSF-1 135 production). 60 Interestingly, adoptive-transfer and cell-tracking experiments revealed phenotype switching of IFN-γ-stimulated proinflammatory (M1) macro phages injected after IRI to M2 macrophages at the onset of tissue repair in the kidney. 60 The relevance of each of these macrophage subsets to AKI is reflected in loss-of-function experiments, which demonstrated that clodronateinduced depletion of (M1) cells before or early after IRI reduces kidney injury, whereas cell depletion at later time points (when M2 macrophages predominate) delays tissue restoration. 60, 136 In a variation of the DTR models described, mice that selectively express the human DTR under the control of the promoter region of γ glutamyl transferase 1, a gene that is specifically expressed in proximal tubule cells, develop AKI in response to injection of DT. 135 In this model, AKI is associated with renal infiltration of a CD11b + DC/macrophage cell type, 135 and administration of liposomal clodronate before DT exposure exacerbated renal injury, increased mortality, and prolonged renal repair, as did concomitant DTR-mediated depletion of both CD11c + DCs, macrophages and proximal renal tubular epithelial cells. 135 These data further demonstrate the role of DC and/or macrophages for tubular recovery after AKI.
Ablation of CD11c + F4/80 + DC/macrophages using liposomal clodronate administered 1 day after renal IRI aggravated injury and retarded tissue regeneration, seemingly by preventing intrinsic IL-10 release by these cells, which was associated with increased proinflammatory cytokine levels and persistence of an inflammatory milieu. 136 In the same model, injury was partly alleviated by adoptive transfer of CD11c + DCs. 136 The protective effects of IL-10 generated by renal DCs have been seen in other models of AKI, including cisplatin-induced nephrotoxicity: renal DCs were demonstrated to express higher levels of IL-10 following cisplatin treatment (with concomitant increases in IL-10 receptor 1 expression). 137 Conversely, enhanced cisplatin-mediated injury was observed in mice lacking IL-10 expression, as well as in chimeric mice lacking IL-10 production only in DCs.
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CD11c + DCs might also provide protection against AKI by modulating the effects of additional cell populations. Findings in cisplatin-mediated AKI are consistent with this hypothesis, suggesting that IL-10 modulates increased expression of ICOS-L on renal DCs. 130 Although not exclusively demonstrated within the kidney, these data imply that the presence of IL-10 may regulate CD4 + T-cell responses. 95 Indeed, the protective role of T REG cells (both CD4 + CD25 + FOXP3 + and CD4 + CD25 + IL-10 + ) 138 induced by CD11c + DCs following renal IRI has been well-recognized. [139] [140] [141] [142] Moreover, infusion of mesenchymal stem cells abrogated renal IRI (reviewed in 143 ), via an effect that was partly mediated by CD11c + DCs. 144 In particular, an immature phenotype of tissue-resident DCs and intrarenal FOXP3 + expression were associated with this renoprotective effect of mesenchymal stem cells, and these features were lost after DT-treatment of CD11c-DTR mice; partial restoration of these characteristics was achieved by the adoptive transfer of CD11c + DCs, although not if they lacked the capacity to produce IL-10.
Increasing evidence suggests that the cytokine milieu associated with sterile inflammation established after IRI is modulated by resident renal cells, including DCs and/or macrophages and RTECs, to drive pathological and reparative processes. In particular, RTECs have been shown to express CSF-1, which promotes macrophage proliferation in situ. 135, 145 However, TLR-activated RTECs limited classical macrophage activation in vitro, and the results of antibody-based inhibition experiments suggesting a role for IL-10 in this regulatory process. 146 Furthermore, a series of in vitro and in vivo experiments demonstrated that RTECs could induce nonprogrammed, quiescent macrophages or programmed proinflammatory M1 macrophages to adopt a M2 phenotype that limited acute renal inflammation and promoted repair. 60 Resident CD11c + F4/80 + renal DC/macrophage numbers remained static after IRI to the kidney, whereas the numbers of infiltrating F4/80 -DCs and/or macrophages with a mature phenotype increased. 147 TNF, as well as IL-6 and CCL2 were produced in greater quantities by the resident renal DCs isolated from ischaemic kidneys than from control kidneys, and in vivo depletion of DCs diminished total TNF secretion within the renal CD45 + cell compartment. 147 Interestingly, renal IRI-mediated induction of interferon regulatory factor 4 (IRF4, an inducible inhibitor of TLR2 and TLR4 signalling) is localized to CD45 + CD11c + DCs/macrophages, and mice lacking IRF4 demonstrated increased renal damage after IRI, which was associated with increased TNF expression and abrogated by liposomal clodronate, suggesting that IRF4 coordinates immunosuppressive effects of these cells by restricting TNF production. 148 These findings suggest that resident renal cells dictate the immune responses that occur in AKI through creation and m odification of the cytokines present within the injured tissues.
Cell-surface receptors that have a role in mediating AKI are often expressed concomitantly on renal 82, 83 although this feature is ameliorated by macrophage depletion in CD11b-DTR mice, 9 or by administration of liposomal clodronate (Table 4) . 80 However, additional studies suggest a proinflammatory role for DCs in UUO, as decreased IFN-γ and IL-17 production by T cells was observed after DC depletion. 152 Three distinct populations of CD11b + macrophages that express either high, intermediate or low levels of Ly6C have been identified to differentiate infiltrating bone-marrow-derived monocytes from tissueresident macrophages. 9 Recruited Ly6C hi cells differentiate within the kidney becoming Ly6C int and then Ly6C lo cells, with the latter demonstrating a profibrotic transcriptional profile. This finding is in keeping with data demonstrating that blockade of CCL2 or its receptor, CCR2, and thus recruitment of inflammatory-type Ly6C hi monocytes impedes macrophage accumulation. 153 
Transplantation
The involvement of DCs and macrophages in renal transplantation has been studied, 154 but limited information is available concerning the effects of standard immunosuppressive agents on renal DC or macrophage numbers and function. Both donor macrophages and DCs are transferred within the allograft at the time of transplantation, and subsequently host DCs and macrophages are recruited into the transplanted kidney. 155, 156 Macrophages proliferate intensely within kidney allografts in the absence of immunosuppression, a process that is promoted by CSF-1. 157 Early animal studies revealed a lack of MHC II antigen induction in kidney allografts when recipients received ciclosporin, compared with untreated transplant recipients. 158 Paradoxically, ciclosporin increased DC number and maturation status in rats. [159] [160] [161] [162] Warm ischaemia alone leads to loss of the CD11c
+ DC subset from syngeneic grafts within 10 weeks, whereas cold ischaemia results in additional loss of the CD103 − DC subset and their replacement by host CD11b + CD11c + CD103 + TNF + DCs, which is associated with progressive T-cell accumulation and IFN-γ production. 161 The ability of DCs to subvert the alloimmune response following transplantation has been documented extensively in the literature (reviewed in 20 ) . Given their typically immature phenotype, 52 renal DCs represent an ideal potential source of regulatory DCs; however, use of these cells is limited by inherent difficulties in isolating adequate populations. Nevertheless, mobilization of mouse renal DCs using FLT3LG increased the absolute numbers that could be isolated for subsequent infusion before cardiac transplantation, which prolonged allograft survival in the absence of immunosuppression. 52 Macrophages are also recognized as important contributors to both acute and chronic allograft injury in animal models. In loss-of-function studies, administration of liposomal clodronate mitigated functional impairment and tissue injury in a rat renal transplant model without affecting the number or activation status of lymphocytes. 162 Similarly, depletion of CD11b + cells in CD11b-DTR mice protected renal allografts from acute injury and rejection. 163 Furthermore, the pharmacological antagonism of the CSF-1-CSF-1R pathway reduced macrophage infiltration, T-cell activation within the allograft, acute cellular rejection and tubulointerstitial injury. 164, 165 Interestingly, such treatment had no effect on systemic activation of T cells and B cells or humoral rejection that occurred later in the renal transplant model. 165 Persistent macrophage infiltration also characterizes the development of chronic allograft nephropathy in rodents, 166 and correspondingly, this manifestation is ameliorated by blockade of macrophage development or activity.
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Renal DCs and macrophages in humans
The studies in rodent models described in the previous sections have provided important insights in the variable and plastic characteristics of renal DCs and macrophages, and provided a basis for increased phenotypic and functional understanding of such cells in humans. However, consensus has not been reached on the identification of distinct cell subtypes in rodents or humans and, therefore, comparison of cell types and extrapolation of data from animal models to human disease is difficult. These issues provide avenues for future research (see Box 2) . Nevertheless, our knowledge of renal DCs and macrophages in the healthy and diseased human kidney has expanded.
In the healthy kidney The DC and macrophage populations present in normal human kidneys have been studied less extensively than those in rodents. 175 Histological alterations reflecting interstitial fibrosis and/or tubular atrophy as well as inflammation were also associated with a macrophage signature in microarray analyses. 176, 177 Whether these data reflect a subset of macrophages associated with acute rejection or a reparative phase to injury remains unclear; nevertheless, glomerular 178, 179 or interstitial 180, 181 macrophage infiltration is a poor prognostic sign and marker of unfavourable graft outcome.
Diseases of the native kidney
Macrophage infiltration has also been shown to be associated with adverse outcomes in native kidney disease; for example, CD68
+ macrophage infiltration is an independent risk factor for progression to end-stage renal disease in patients with membranous nephropathy. 182 Evaluation of biopsy tissues from patients with a diverse range of chronic kidney diseases demonstrated that macrophage infiltration correlated with both the degree of chronic damage and serum creatinine levels, 183 and that these cells co-localized to areas of capillary rarefaction, implicating a role for macrophages in microvasculature injury. 184 Early studies detected CD1b + DCs within areas of active interstitial inflammation and glomerular crescent formation. 185 Observations regarding DC infiltration have also been made in the kidneys of patients with IgA nephropathy, with the findings indicating that the number and anatomical location of these cells alters in the disease setting. 169 In patients with lupus nephritis, increased numbers of putative cDC that express BDCA-1, BDCA-3 (also known as CD141 and thymomodulin), and BDCA-4 (CD304; neuropilin-1) have been reported. 186 BDCA-1 + myeloid DCs were also associated with C1q in kidney tissues from patients with severe lupus nephritis, with concordant animal model data suggesting that intrinsic renal myeloid DCs contribute to local C1q synthesis. 110 In human glomerulonephritis, mononuclear-cell subtypes might be compartmentally separated, with tubulointerstitial cell accumulation of CD68 + DC-SIGN + DCs cells and intraglomerular localization of CD68 + DC-SIGN − macro phages. A correlation between the number of tubulo interstitial DCs and degree of renal injury has also been suggested. 187 Mature DC-LAMP + DCs are not present in healthy kidneys but are evident at low numbers in the kidneys of patients with renal disease, including lupus nephritis. 169, 188 In addition, a study in patients with chronic kidney disease has demonstrated increased BDCA-3 high CLEC9A + and BDCA-1 + CD1a − DC-SIGN − myeloid DCs, as well as pDCs, in human kidney biopsy samples with histological evidence of fibrosis, compared with biopsy samples without fibrosis or healthy tissue samples. 189 The myeloid DC phenotype of some of the renal DCs observed in this study suggests that they were derived from the peripheral circulation, and these cells were implicated as the predominant source of the elevated TGF-β levels in biopsy samples from fibrotic kidneys. 189 Although the presence of pDC within the diseased kidney has been demonstrated in mouse models, the role of these cells in human disease has been disputed. The contribution of pDC to renal pathology has been demonstrated most consistently in lupus nephritis, where secretion of IL-18 by resident glomerular cells is a potent chemoattractant for IL-18-receptor-expressing pDC. 190, 191 BDCA-2 + ChemR23 (Chemokine receptorlike 1) + pDC have been demonstrated to be present in the kidney in the context of severe lupus nephritis. 186 pDC are also reported to be evident in increased numbers in kidney transplants with delayed graft function, compared with the setting of nephrotoxicity associated with calcineurin inhibitors, in which the myeloid DCs are preponderant. 192 Cross-talk between T cells and DCs is well-recognized in mouse models, and evidence from human kidney samples suggests that a similar inter-relationship is involved in the initiation of immunological responses in the kidney. In particular, biopsy tissues from patients with ANCA-associated vasculitis revealed a close proximity between CD3 + T cells and DC-SIGN + DCs. 193 Further more, clusters of CD21 + follicular DCs that express the B-lymphocyte-specific chemokine CXCL13 have also been demonstrated in tertiary lymphoid structures that develop within the renal parenchyma following chronic antigen stimulation (in the setting of renal allografts), 194 and neolymphangiogenesis with admixed CD4 + T cells, CD8 + T cells, CD20 + B cells, S-100 + cDCs and pDCs. 195 These observations suggest that intrarenal antigen presentation by DCs to T cells and B cells promotes chronic, immune-cell-mediated inflammatory responses in various kidney diseases; thus, renal DCs (and/or macrophages) probably have key roles in mediating kidney disease.
Conclusions
Renal DCs and macrophages are phenotypically and functionally heterogeneous cells that regulate tissue responses to renal injury and disease. The considerable overlap between DCs and macrophages represents a continuum of phenotype, as well as plasticity of cells of the myeloid-monocytic lineage both in vivo and in vitro. Our knowledge of renal DC and macrophage function lags behind that described for these cell types in other organs; however, progress has been made in addressing this limitation through advances in cell isolation, identification, in vivo propagation and the use of innovative geneticallymodified mouse models. The central role of renal DCs and macrophages in homeostasis, as well as their capacity to modulate physiological function to drive immune or nonimmune disorders, is increasingly recognized. These cells provide a reservoir for ongoing immunosurveillance within the renal tubulointerstitium extending to the draining lymph nodes, in addition to affording an immune privileged site within the glomerulus.
Extensive small-animal work has provided an important basis for increased phenotypic and functional understanding; however, a consensus regarding precise cell identification and extrapolation to human kidney disease is lacking, providing avenues for future research. Importantly, after several decades of research the question of whether renal DCs and macrophages constitute sufficiently specific targets for therapeutic intervention to potentially ameliorate kidney disease progression remains, necessitating further study.
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